Agnieszka Rybarczyk

Prognostic significance of VHL, HIF1A, HIF2A, VEGFA and p53 expression in patients with clear‑cell renal cell carcinoma treated with sunitinib as first‑line treatment

Piotr Wierzbicki, Anna Kotulak‐Chrząszcz, Agata Wrońska et al. · International Journal of Oncology · 2019 · 44 citations · Full text

Surgical Oncology, Renal Inflammation, Pathology +18

Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome

Agnieszka Rybarczyk, Agata Wrońska, Marcin Matuszewski et al. · Oncology Reports · 2017 · 39 citations · Full text

Poor Outcome, Renal Pathology, Pathology +20

Vitamin D and its low calcemic analogs modulate the anticancer properties of cisplatin and dacarbazine in the human melanoma A375 cell line

Anna Piotrowska, Justyna Wierzbicka, Agnieszka Rybarczyk et al. · International Journal of Oncology · 2019 · 32 citations · Full text

Dermatology, Cancer Biology, Tumor Biology +16

Protein and siRNA delivery by transportan and transportan 10 into colorectal cancer cell lines

Piotr Wierzbicki, Marzena Kogut-Wierzbicka, Jarosław Ruczyński et al. · Folia Histochemica et Cytobiologica · 2014 · 31 citations · Full text

Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma

Piotr Wierzbicki, Agata Wrońska, Agnieszka Rybarczyk et al. · International Journal of Oncology · 2015 · 22 citations · Full text

Ccrcc Progression, Urology, Oncology +14